Bottom line
How much do IBB and FBIOX overlap?
34% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 32.8% of IBB's assets and 23.7% of FBIOX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBB and FBIOX have in common
| Holding | % of IBB | % of FBIOX | Overlap |
|---|---|---|---|
| Gilead Sciences, Inc. | 7.52% | 4.82% | 4.82% |
| Amgen, Inc. | 7.50% | 6.53% | 6.53% |
| Alnylam Pharmaceuticals, Inc. | 5.68% | 2.93% | 2.93% |
| Argenx SE | 3.15% | 2.25% | 2.25% |
| Insmed, Inc. | 2.95% | 2.25% | 2.25% |
| Natera, Inc. | 2.11% | 1.41% | 1.41% |
| Biogen, Inc. | 2.03% | 1.26% | 1.26% |
| Madrigal Pharmaceuticals, Inc. | 0.92% | 0.93% | 0.92% |
| Moderna, Inc. | 0.88% | 1.28% | 0.88% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBB
- BlackRock Funds III — 13.18%
- Vertex Pharmaceuticals, Inc. — 7.66%
- Regeneron Pharmaceuticals, Inc. — 5.70%
- IQVIA Holdings, Inc. — 3.18%
- Mettler-Toledo International, Inc. — 2.49%
- BeOne Medicines Ltd. — 2.11%
- United Therapeutics Corp. — 1.82%
- Waters Corp. — 1.77%
- Incyte Corp. — 1.62%
- Illumina, Inc. — 1.41%
- Genmab A/S — 1.38%
- Neurocrine Biosciences, Inc. — 1.34%
- Medpace Holdings, Inc. — 1.16%
- Exelixis, Inc. — 1.07%
- Ionis Pharmaceuticals, Inc. — 1.03%
Only in FBIOX
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Fidelity Revere Street Trust — 3.35%
- Praxis Precision Medicines Inc. — 2.47%
- Ascendis Pharma A/s — 2.04%
- Revolution Medicines Inc — 2.02%
- Ucb Sa — 2.00%
- Jazz Pharmaceuticals Plc — 1.84%
- Scholar Rock Holding Corp — 1.55%
- Axsome Therapeutics Inc — 1.28%
- Protagonist Therapeutics Inc — 1.15%
- Roivant Sciences Ltd — 1.13%
- Cogent Biosciences Inc — 1.07%
- Tango Therapeutics Inc — 0.98%
- Celcuity Inc — 0.95%
Asset mix
| Asset type | IBB | FBIOX |
|---|---|---|
| Stocks | 99.8% | 99.0% |
| Cash & short-term funds | 13.4% | 3.5% |
| Preferred stock | — | 0.9% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)
Country mix
| Country | IBB | FBIOX |
|---|---|---|
| US | 98.6% | 88.5% |
| NL | 4.3% | 2.9% |
| CH | 2.7% | 1.1% |
| DK | 2.2% | 2.6% |
| BE | — | 2.0% |
| IE | 0.5% | 2.0% |
| BM | 0.7% | 1.1% |
| GB | 1.0% | 0.8% |
Source: SEC Form N-PORT (periods Sep 30, 2025 / May 31, 2026)
Check another pair
FAQ
How much do IBB and FBIOX overlap?
What stocks do IBB and FBIOX have in common?
Should I own both IBB and FBIOX?
Which holds more stocks, IBB or FBIOX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.